Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biosource International -- Ignore unavailable to you. Want to Upgrade?

To: steven Probst who wrote (650)	3/29/1999 10:43:00 PM
From: Timothy Grimes	Read Replies (1) \| Respond to of 696

Not good news. We new the write off would be a big one. I still need to examine the numbers closer, but what bothers me is the lack of core business growth. Sales were flat from last year. That is the big problem here. The acquisition will help the top line but Wall Street will not look to BioSource as an investment if they can't grow their core business. They say they released 22 new products last year. So what! if all they did was replace lost revenue from other products. I am tired of this shit and tempted to cash it in. Seems whoever drove the share price past $3 is the big loser. What do you think Joe? Tim